§ Mr. McNamaraasked the Secretary of State for Social Services if, pursuant to his answer of 26 January, Official Report, column 92, he will name the locations of the principal overseas manufacturing sites of Generics (UK) Ltd. that have been inspected as part of his Department's regular inspection programme; and if he will name the location of the site that is scheduled to be visited early in February.
§ Mr. NewtonInformation about manufacturing sites, like other information contained in licence applications under the Medicines Act, is commercially confidential and is not disclosed by the licensing authority.